Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Gary L. Pattee, Angela Genge, Philippe Couratier, Christian Lunetta, Gen Sobue, Masashi Aoki, Hiide Yoshino, Carlayne E. Jackson, James Wymer, Alejandro Salah & Sally Nelson. (2023) Oral Edaravone – Introducing a Flexible Treatment Option for Amyotrophic Lateral Sclerosis. Expert Review of Neurotherapeutics 0:0, pages 1-8.
Read now
Read now
Andrea Barp, Francesca Gerardi, Andrea Lizio, Valeria Ada Sansone & Christian Lunetta. (2020) Emerging Drugs for the Treatment of Amyotrophic Lateral Sclerosis: A Focus on Recent Phase 2 Trials. Expert Opinion on Emerging Drugs 25:2, pages 145-164.
Read now
Read now
Articles from other publishers (28)
Hussein maitham Qassim, Bagher Seyedalipour, Payam Baziyar & Salman Ahamady-Asbchin. (2023) Polyphenolic flavonoid compounds act as the inhibitory potential of aggregation process: Implications for the prevention and therapeutics against FALS-associated D101G SOD1 mutant. Computational Biology and Chemistry 107, pages 107967.
Crossref
Crossref
Abdul Rashid Issahaku, Mahmoud A. A. Ibrahim, Namutula Mukelabai & Mahmoud E. S. Soliman. (2023) Intermolecular And Dynamic Investigation of The Mechanism of Action of Reldesemtiv on Fast Skeletal Muscle Troponin Complex Toward the Treatment of Impaired Muscle Function. The Protein Journal 42:4, pages 263-275.
Crossref
Crossref
Rishabh Chaudhary & Vikas Mishra. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences
1
18
.
Hamza Dakhil Zaji, Bagher Seyedalipour, Haider Munzer Hanun, Payam Baziyar, Saman Hosseinkhani & Mona Akhlaghi. (2023) Computational insight into in silico analysis and molecular dynamics simulation of the dimer interface residues of ALS-linked hSOD1 forms in apo/holo states: a combined experimental and bioinformatic perspective. 3 Biotech 13:3.
Crossref
Crossref
Angela Genge, Gary L. Pattee, Gen Sobue, Masashi Aoki, Hiide Yoshino, Philippe Couratier, Christian Lunetta, Susanne Petri, Daniel Selness, Sachin Bidani, Manabu Hirai, Takeshi Sakata, Alejandro Salah, Stephen Apple, Art Wamil, Alexander Kalin & Carlayne E. Jackson. (2022) Oral edaravone demonstrated a favorable safety profile in patients with amyotrophic lateral sclerosis after 48 weeks of treatment. Muscle & Nerve 67:2, pages 124-129.
Crossref
Crossref
Long-Fang Tu, Tian-Ze Zhang, Yang-Fan Zhou, Qing-Qing Zhou, Hai-Biao Gong, Lei Liang, Lin-Na Hai, Nan-Xin You, Yang Su, Yong-Jun Chen, Xu-Kai Mo, Chang-Zheng Shi, Liang-Ping Luo, Wan-Yang Sun, Wen-Jun Duan, Hiroshi Kurihara, Yi-Fang Li & Rong-Rong He. (2023) GPX4 deficiency-dependent phospholipid peroxidation drives motor deficits of ALS. Journal of Advanced Research 43, pages 205-218.
Crossref
Crossref
E. Srinivasan, G. Chandrasekhar & R. Rajasekaran. (2022) Probing the polyphenolic flavonoid, morin as a highly efficacious inhibitor against amyloid(A4V) mutant SOD1 in fatal amyotrophic lateral sclerosis. Archives of Biochemistry and Biophysics 727, pages 109318.
Crossref
Crossref
Angela Genge, Benjamin Rix Brooks, Björn Oskarsson, Alexander Kalin, Ming Ji, Stephen Apple & Laura Bower. (2022) Analysis of the US Safety Data for Edaravone (Radicava®) From the Third Year After Launch. Drugs in R&D 22:3, pages 205-211.
Crossref
Crossref
Rishabh Chaudhary, Vipul Agarwal, Mujeeba Rehman, Arjun Singh Kaushik & Vikas Mishra. (2022) Genetic architecture of motor neuron diseases. Journal of the Neurological Sciences 434, pages 120099.
Crossref
Crossref
Cheng Li, Yu Zhu, Wenzhi Chen, Menghua Li, Mi Yang, Ziyang Shen, Yiyi Zhou, Lulu Wang, Huan Wang, Shu Li, Jiacheng Ma, Mengni Gong & Renshi Xu. (2022) Circulating NAD+ Metabolism-Derived Genes Unveils Prognostic and Peripheral Immune Infiltration in Amyotrophic Lateral Sclerosis. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Bochao Liu, Mo Li, Lingyan Zhang, Zhiguo Chen & Paul Lu. (2022) Motor neuron replacement therapy for amyotrophic lateral sclerosis. Neural Regeneration Research 17:8, pages 1633.
Crossref
Crossref
Magisetty Obulesu. 2022. Plant Extracts in Neurodegenerative Diseases. Plant Extracts in Neurodegenerative Diseases
101
115
.
C. Quarracino, M. Bendersky, R. Rey & G. E. Rodríguez. (2020) Logistics and safety of edaravone treatment for amyotrophic lateral sclerosis: experience in Argentina. Acta Neurologica Belgica 121:6, pages 1519-1523.
Crossref
Crossref
Emad H. M. Hassanein, Marwa A. Ahmed, Ahmed M. Sayed, Eman K. Rashwan, Omnia A. M. Abd El‐Ghafar & Ayman M. Mahmoud. (2021) Edaravone mitigates hemorrhagic cystitis by modulating Nrf2, TLR‐4/NF‐κB, and JAK1/STAT3 signaling in cyclophosphamide‐intoxicated rats. Journal of Biochemical and Molecular Toxicology 35:11.
Crossref
Crossref
Scott E. Collibee, Gustave Bergnes, Chihyuan Chuang, Luke Ashcraft, Jeffrey Gardina, Marc Garard, Chris R. Jamison, Kevin Lu, Pu-Ping Lu, Alexander Muci, Antonio Romero, Ellen Valkevich, Wenyue Wang, Jeffrey Warrington, Bing Yao, Nickie Durham, James Hartman, Anna Marquez, Aaron Hinken, Julia Schaletzky, Donghong Xu, Darren T. Hwee, David Morgans, Fady I. Malik & Bradley P. Morgan. (2021) Discovery of Reldesemtiv, a Fast Skeletal Muscle Troponin Activator for the Treatment of Impaired Muscle Function. Journal of Medicinal Chemistry 64:20, pages 14930-14941.
Crossref
Crossref
Alec S. T. Smith, Changho Chun, Jennifer Hesson, Julie Mathieu, Paul N. Valdmanis, David L. Mack, Byung-Ok Choi, Deok-Ho Kim & Mark Bothwell. (2021) Human Induced Pluripotent Stem Cell-Derived TDP-43 Mutant Neurons Exhibit Consistent Functional Phenotypes Across Multiple Gene Edited Lines Despite Transcriptomic and Splicing Discrepancies. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Mohammad Mehdi Ommati, Hanie Attari, Asma Siavashpour, Marzieh Shafaghat, Negar Azarpira, Hasti Ghaffari, Leila Moezi & Reza Heidari. (2021) Mitigation of cholestasis-associated hepatic and renal injury by edaravone treatment: Evaluation of its effects on oxidative stress and mitochondrial function. Liver Research 5:3, pages 181-193.
Crossref
Crossref
Rakesh Sahu, Shubham Upadhayay & Sidharth Mehan. (2021) Inhibition of extracellular regulated kinase (ERK)-1/2 signaling pathway in the prevention of ALS: Target inhibitors and influences on neurological dysfunctions. European Journal of Cell Biology 100:7-8, pages 151179.
Crossref
Crossref
Hideki Houzen, Takahiro Kano, Kazuhiro Horiuchi, Masahiro Wakita, Azusa Nagai & Ichiro Yabe. (2021) Improved Long-Term Survival with Edaravone Therapy in Patients with Amyotrophic Lateral Sclerosis: A Retrospective Single-Center Study in Japan. Pharmaceuticals 14:8, pages 705.
Crossref
Crossref
Mariapia Vairetti, Laura Giuseppina Di Pasqua, Marta Cagna, Plinio Richelmi, Andrea Ferrigno & Clarissa Berardo. (2021) Changes in Glutathione Content in Liver Diseases: An Update. Antioxidants 10:3, pages 364.
Crossref
Crossref
Sunny Kumar, Daniel Phaneuf & Jean-Pierre Julien. (2020) Withaferin-A Treatment Alleviates TAR DNA-Binding Protein-43 Pathology and Improves Cognitive Function in a Mouse Model of FTLD. Neurotherapeutics 18:1, pages 286-296.
Crossref
Crossref
Giovanna Menduti, Daniela Maria Rasà, Serena Stanga & Marina Boido. (2020) Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment. Frontiers in Pharmacology 11.
Crossref
Crossref
Juan Fernando Ortiz, Sawleha Arshi Khan, Amr Salem, Zayar Lin, Zafar Iqbal & Nusrat Jahan. (2020) Post-Marketing Experience of Edaravone in Amyotrophic Lateral Sclerosis: A Clinical Perspective and Comparison With the Clinical Trials of the Drug. Cureus.
Crossref
Crossref
Michelle Vu, Kathryn Tortorice, Jennifer Zacher, Diane Dong, Kwan Hur, Rongping Zhang, Chester B. Good, Peter A. Glassman & Francesca E. Cunningham. (2020) Assessment of Use and Safety of Edaravone for Amyotrophic Lateral Sclerosis in the Veterans Affairs Health Care System. JAMA Network Open 3:10, pages e2014645.
Crossref
Crossref
Richard W. Orrell & Roberto J. Guiloff. (2020) Clinical aspects of motor neurone disease. Medicine 48:9, pages 607-611.
Crossref
Crossref
Michael S. Bereman, Kaylie I. Kirkwood, Tharani Sabaretnam, Sarah Furlong, Dominic B. Rowe, Gilles J. Guillemin, Allyson L. Mellinger & David C. Muddiman. (2020)
Metabolite Profiling Reveals Predictive Biomarkers and the Absence of β-Methyl Amino-
l
-alanine in Plasma from Individuals Diagnosed with Amyotrophic Lateral Sclerosis
. Journal of Proteome Research 19:8, pages 3276-3285.
Crossref
Crossref
Sandra Carrera-Juliá, Mari Luz Moreno, Carlos Barrios, Jose Enrique de la Rubia Ortí & Eraci Drehmer. (2020) Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review. Frontiers in Physiology 11.
Crossref
Crossref
. (2019) Edaravone. Reactions Weekly 1780:1, pages 143-143.
Crossref
Crossref